SSBP2 and prostate carcinoma: The majority of previous studies have suggested a tumor-suppressive role of SSBP2, which is silenced by promoter hypermethylation in most solid tumors, such as prostate cancer, esophageal squamous cell carcinoma, ovarian cancer, and gallbladder cancer.